Skip to main content

CSW Industrials Completes Previously Announced Accretive, Complementary, and Synergistic Acquisition of Motors & Armatures Parts

DALLAS, Nov. 04, 2025 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (NYSE: CSW) (the “Company” or “CSW”) today announced the Company has completed the previously announced acquisition of Motors & Armatures Parts (“MARS Parts”) for approximately $650 million in cash. The cash purchase price, excluding earn-out, represents 10.4x pro-forma trailing twelve-month (“TTM”) EBITDA adjusted for identified synergies and is approximately 12.4x MARS Parts’ estimated adjusted TTM EBITDA of $52.3 million. This strategic acquisition expands CSW’s existing product portfolio in the profitable heating, ventilation, air conditioning, and refrigeration (“HVAC/R”) end market with the addition of motors, capacitors, other HVAC/R electrical components and equipment installation offerings as well as other components used by the pro trades for HVAC/R repairs...

Continue reading

PEDEVCO Announces Closing of Transformative Merger to Become Premier Rockies Operator

HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — PEDEVCO Corp. (NYSE American: PED), (“PEDEVCO” or the “Company”) announced today that it has merged with certain portfolio companies (the “Portfolio Companies”) controlled by Juniper Capital Advisors, L.P. (together with affiliates, “Juniper”), which own substantial oil-weighted producing assets and significant leasehold interests with future drilling inventory located in the Northern DJ and Powder River Basins (the “Transaction”). As consideration, PEDEVCO issued 10,650,000 shares of PEDEVCO Series A Convertible Preferred (the “Convertible Preferred Shares”) stock, convertible into 106,500,000 shares of common stock of the Company, and PEDEVCO has refinanced the Portfolio Companies’ previously outstanding debt and preferred equity. Simultaneously with the closing of the Transaction, PEDEVCO...

Continue reading

Questex Strengthens its Leadership Position in the Booming $88.2 Billion Life Sciences Industry, Acquires The Conference Forum and Versalinx Global Events

Acquisitions Complement Questex’s Powerhouse Fierce Healthcare & Life Sciences Assets NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Questex, a leading authority in the healthcare and life sciences sector, today announces the acquisitions of The Conference Forum and Versalinx Global Events. The life sciences industry is booming with $88.2 billion in sales (2024) and is expected to grow to $269.56 billion by 2034, at a CAGR of 12% (Towards Healthcare). The acquisitions of The Conference Forum and Versalinx Global Events support Questex’s overarching growth strategy focused on both organic and strategic expansion within fast-evolving, high-growth industries, enhancing its powerhouse global healthcare & life sciences portfolio. By integrating specialized expertise, Questex can provide access to a larger audience and networks,...

Continue reading

Arctic Wolf Invests to Advance Aurora Endpoint Security with AI-Powered Ransomware Prevention and Rollback Capabilities

Acquisition of UpSight Security will enhance the Aurora Platform with predictive AI to strengthen protection and accelerate endpoint security outcomes EDEN PRAIRIE, Minn., Nov. 04, 2025 (GLOBE NEWSWIRE) — Arctic Wolf®, a global leader in security operations, today announced plans to enhance Aurora™ Endpoint Security with upcoming AI-powered ransomware prevention and rollback capabilities. Through the acquisition of UpSight Security, Arctic Wolf will accelerate the development and future delivery of these features, expanding its ability to protect organizations against ransomware, credential theft, and other advanced endpoint attacks. After the integration, Arctic Wolf will leverage UpSight Security’s patented technology to enhance Aurora Endpoint Security with predictive, on-device AI models that continuously analyze billions...

Continue reading

Berlin Packaging Strengthens Its Presence in Spain with the Acquisition of Jurcal Packaging

Through this operation, the company expands its packaging offering for the pharmaceutical and veterinary sectors in Spain MILAN, Nov. 04, 2025 (GLOBE NEWSWIRE) — Berlin Packaging, the world’s largest Hybrid Packaging Supplier®, has announced the acquisition of Jurcal, a Spanish distributor specialising in packaging solutions for the pharmaceutical and veterinary industries. Founded in 1982 and based in Alcobendas, Madrid, Jurcal is led by siblings Julián and Susana Calderón Braña. The company supplies specialized glass and plastic containers, as well as technically advanced dispensers and closures, serving small, medium, and large-scale customers throughout the Iberian Peninsula. In addition, Jurcal offers a wide range of sterilization, decoration, and quality control services for the pharmaceutical and veterinary markets. “We...

Continue reading

Presidio Expands in the Mid-Atlantic with Acquisition of Achieve One

Combined capabilities expand access to advanced cloud and digital transformation solutions and expertise NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Presidio, a leading global technology services and solutions provider, today announced the acquisition of Achieve One, a systems integrator and cloud solutions provider based in Virginia. The acquisition strengthens Presidio’s scale and technical capabilities across the Virginia and Washington, D.C. region, advancing its strategy of building regional density near high-value enterprise and public sector accounts. Achieve One has built a strong reputation for modernizing IT infrastructure and accelerating digital transformation for clients across the public sector, manufacturing, financial services, and healthcare markets. The company focuses on helping organizations modernize their IT...

Continue reading

Leviathan Gold Announces Receipt of Conditional Approval of the TSXV to Acquire Cura Exploration Botswana Corp. and its 100% Interest in Kalahari Copper and Uranium Exploration Portfolios, Botswana

VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) — Leviathan Gold Ltd. (“Leviathan” or the “Company”) (LVX – TSXV, LVXFF – OTC, 0GP – FSE) is pleased to announce that it has received conditional approval of the TSX Venture Exchange (the “TSXV”) with respect to the previously announced proposed acquisition (the “Transaction”) of all of the issued and outstanding securities of Cura Exploration Botswana Corp. (“Cura”), further to its previous announcements on June 19, 2025, July 16, 2025, August 18, 2025, September 11, 2025 and October 20, 2025. Additionally, the Company announces that it has entered into an amending agreement dated October 31, 2025 (the “Amending Agreement”) to amend the terms of the amalgamation agreement dated September 11, 2025 (the “Amalgamation Agreement”) between the Company, Cura and 1555801 B.C....

Continue reading

TWFG, Inc. Acquires Alabama Insurance Agency, Inc. Expanding Its Southeastern Footprint

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) — TWFG, Inc. (NASDAQ: TWFG), a leading independent insurance distribution platform, announced today that it has acquired Alabama Insurance Agency, Inc., and its 20 affiliated locations across the state. This strategic acquisition strengthens TWFG’s presence in the Southeastern United States and reinforces its commitment to delivering personalized insurance solutions through a growing network of independent agents. Alabama Insurance Agency, known for its strong community ties and customer-first approach, will benefit from TWFG’s national scale, growing brand recognition, technology infrastructure, and carrier relationships. “Choosing TWFG Insurance as our partner was an easy choice. It’s a win for our customers, a win for our staff, and a win for our carrier partners,” stated...

Continue reading

Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 SOLANA BEACH, Calif., and VERO BEACH, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK) (“Evoke”), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, and QOL Medical, LLC (“QOL Medical”), a privately held biopharmaceutical company specializing in treatments for GI and rare diseases, today announced that they have entered into a definitive agreement pursuant to which QOL Medical will acquire Evoke for $11.00 per share in cash at closing. The transaction has been unanimously approved by the Boards of Directors...

Continue reading

Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)

MELBOURNE, Australia, Nov. 04, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced a strategic initiative to pursue the acquisition of Digital Asset Treasury (DAT) companies that are currently trading below their Market Cap to Net Asset Value (MNAV). The Company’s management believes that acquiring undervalued DAT entities presents a compelling opportunity to strengthen Propanc’s balance sheet, diversify its asset base, and create long-term shareholder value. These DAT companies typically hold substantial reserves of leading digital assets such as Bitcoin (BTC) and Ethereum (ETH) on their balance sheets. According to public filings and data compiled by CoinMarketCap.com,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.